Adoption of New Glucose-Lowering Medications in the U.S. - The Case of SGLT2 Inhibitors: Nationwide Cohort Study

Rozalina G. McCoy, Hayley J. Dykhoff, Lindsey Sangaralingham, Joseph S. Ross, Pinar Karaca-Mandic, Victor M. Montori, Nilay D. Shah

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Adoption of New Glucose-Lowering Medications in the U.S. - The Case of SGLT2 Inhibitors: Nationwide Cohort Study'. Together they form a unique fingerprint.

Medicine & Life Sciences